S-1-Based versus capecitabine-based preoperative chemoradiotherapy in the treatment of locally advanced rectal cancer: a matched-pair analysis.

S-1-Based versus capecitabine-based preoperative chemoradiotherapy in the treatment of locally advanced rectal cancer: a matched-pair analysis.

OBJECTIVE: The aim of this paper was to compare the efficacy and safety of S-1-based and capecitabine-based preoperative chemoradiotherapy regimens in patients with locally advanced rectal cancer through a retrospective matched-pair analysis. MATERIALS AND METHODS: Between Jan 2010 and Mar 2014, 24...

Full description

Bibliographic Details
Main Authors:	Meng Su, Lu-Cheng Zhu, Hang-Ping Wei, Wen-Hua Luo, Rui-Fang Lin, Chang-Lin Zou
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4152119?pdf=render

Similar Items

Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
by: Anchuan Li, et al.
Published: (2022-07-01)

Adding Consolidation Capecitabine to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Propensity-Matched Comparative Study
by: Yifang Fang, et al.
Published: (2022-01-01)

Oral fluorpyrimidines in preoperative chemoradiotherapy for operable rectal cancer
by: Yu. A. Barsukov, et al.
Published: (2016-01-01)

A review of preoperative chemoradiotherapy for lower rectal cancer
by: Naohito Beppu, et al.
Published: (2017-07-01)

Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before surgery in patients with locally advanced rectal cancer
by: Aly Mohammed Azmy, et al.
Published: (2022-01-01)

Rectal adenocarcinoma with oncocytic features: possible relationship with preoperative chemoradiotherapy.
by: Rouzbahman, M, et al.
Published: (2006)

Organ preservation for early rectal cancer using preoperative chemoradiotherapy
by: Gyung Mo Son
Published: (2023-06-01)

Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer
by: Yu Lin, et al.
Published: (2019-10-01)

Mean Corpuscular Volume as a Predictive Factor of Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer
by: Wen-Yi Zhang, et al.
Published: (2018-01-01)

p53 status and the regression of rectal cancer following preoperative chemoradiotherapy
by: Wheeler, J, et al.
Published: (2000)

Beware of Early Relapse in Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy
by: Seul Gi Oh, et al.
Published: (2020-12-01)

Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer
by: Ming-Yii Huang, et al.
Published: (2018-03-01)

Preoperative chemoradiation in locally advanced rectal cancer: A comparison of bolus 5-fluorouracil/leucovorin and capecitabine
by: Adnan Yoney, et al.
Published: (2014-01-01)

Predictors and histological effects of preoperative chemoradiotherapy for rectal cancer and control of lateral lymph node metastasis
by: Hiroshi Miyakita, et al.
Published: (2022-07-01)

Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer
by: Jose Carlos Benitez, et al.
Published: (2021-05-01)

Optimal time intervals between preoperative radiotherapy or chemoradiotherapy and surgery in rectal cancer?
by: Bengt eGlimelius
Published: (2014-04-01)

Radiomics signature as a new biomarker for preoperative prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
by: Zhaohe Zhang, et al.
Published: (2021-05-01)

Robotic versus laparoscopic surgery for rectal cancer after neoadjuvant chemoradiotherapy: A propensity-score matching analysis
by: Tzu-Chun Chen, et al.
Published: (2022-08-01)

Preoperative Chemoradiotherapy Versus Postoperative Chemoradiotherapy for Patients With Locally Advanced Gastric Cancer: A Retrospective Study Based on Propensity Score Analyses
by: Wang Yang, et al.
Published: (2020-10-01)

ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group
by: Maximilian Fleischmann, et al.
Published: (2022-05-01)

Artemis as Predictive Biomarker of Responsiveness to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
by: Hai Liu, et al.
Published: (2024-01-01)

Efficacy of preoperative chemoradiotherapy in patients with cT2N0 distal rectal cancer
by: Min Young Park, et al.
Published: (2023-06-01)

Translational Potential of MicroRNAs for Preoperative Staging and Prediction of Chemoradiotherapy Response in Rectal Cancer
by: Tana Machackova, et al.
Published: (2019-10-01)

Correlation between T stage and lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy
by: Seijong Kim, et al.
Published: (2022-10-01)

Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
by: Chie Takasu, et al.
Published: (2022-12-01)

Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report
by: Yuki Nakamura, et al.
Published: (2018-09-01)

Oncologic Outcomes of Organ Preserving Approaches in Patients With Rectal Cancer Treated With Preoperative Chemoradiotherapy
by: In Ja Park, et al.
Published: (2019-04-01)

Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer
by: Attila Paszt, et al.
Published: (2022-12-01)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy
by: Alfonso Martín-Carnicero, et al.
Published: (2022-10-01)

HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer
by: Yi-Jung Huang, et al.
Published: (2022-08-01)

Utility of RGNEF in the Prediction of Clinical Prognosis in Patients with Rectal Cancer Receiving Preoperative Concurrent Chemoradiotherapy
by: Chih-I. Chen, et al.
Published: (2021-12-01)

HLA class I expression and its alteration by preoperative hyperthermo-chemoradiotherapy in patients with rectal cancer.
by: Hiro Sato, et al.
Published: (2014-01-01)

What are the most important prognostic factors in patients with residual rectal cancer after preoperative chemoradiotherapy?
by: Sol-Min Kim, et al.
Published: (2019-05-01)

Local recurrence after surgery of locally advanced rectal cancer treated with or without preoperative chemoradiotherapy
by: Ðurić Mladen, et al.
Published: (2020-01-01)

Analysis of influencing factors of no/low response to preoperative concurrent chemoradiotherapy in locally advanced rectal cancer.
by: Fengpeng Wu, et al.
Published: (2020-01-01)

Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis
by: Yan Wang, et al.
Published: (2018-06-01)

Prognostic impact of acellular mucin pools towards the patients with locally advanced rectal cancer achieving pathological complete response after preoperative chemoradiotherapy
by: Lin Zhang, et al.
Published: (2020-03-01)

Meta-Analysis on the Neutrophil-Lymphocyte Ratio in Rectal Cancer Treated With Preoperative Chemoradiotherapy: Prognostic Value of Pre- and Post-Chemoradiotherapy Neutrophil-Lymphocyte Ratio
by: Soo Jin Lee, et al.
Published: (2022-02-01)

Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis.
by: Yoon Jin Cha, et al.
Published: (2019-01-01)